2019 ACOG实践简报:胎儿生长受限(No.204)

2019-01-24 美国妇产科医师学会 Obstet Gynecol. 2019 Feb;133(2):e97-e109.

2019年1月,美国妇产科医师学会(ACOG)发布了关于胎儿生长受限的实践指南临时更新版本。胎儿生长受限也称宫内生长受限,是妊娠常见并发症多与各种不良围产结局相关。本文主要针对胎儿生长受限的相关术语,病因学,诊断,监测以及分娩的管理提出指导建议。

中文标题:

2019 ACOG实践简报:胎儿生长受限(No.204)

英文标题:

ACOG Practice Bulletin No. 204: Fetal Growth Restriction.

发布机构:

美国妇产科医师学会

发布日期:

2019-01-24

简要介绍:

2019年1月,美国妇产科医师学会(ACOG)发布了关于胎儿生长受限的实践指南临时更新版本。胎儿生长受限也称宫内生长受限,是妊娠常见并发症多与各种不良围产结局相关。本文主要针对胎儿生长受限的相关术语,病因学,诊断,监测以及分娩的管理提出指导建议。 

拓展指南:胎儿相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 ACOG实践简报:胎儿生长受限(No.204))] GetToolGuiderByIdResponse(projectId=1, id=3f2fe1c00169e9a3, title=2019 ACOG实践简报:胎儿生长受限(No.204), enTitle=ACOG Practice Bulletin No. 204: Fetal Growth Restriction., guiderFrom=Obstet Gynecol. 2019 Feb;133(2):e97-e109., authorId=null, author=, summary=2019年1月,美国妇产科医师学会(ACOG)发布了关于胎儿生长受限的实践指南临时更新版本。胎儿生长受限也称宫内生长受限,是妊娠常见并发症多与各种不良围产结局相关。本文主要针对胎儿生长受限的相关术语,病因学,诊断,监测以及分娩的管理提出指导建议。 , cover=, journalId=null, articlesId=null, associationId=357, associationName=美国妇产科医师学会, associationIntro=美国妇产科医师学会(ACOG),前身为美国妇产科学院,是一个美国妇产科妇科专业医生的专业协会。ACOG拥有超过55000名会员,其中90% 的会员是在美国经执业认证的妇产科医生。Obstetrics & Gynecology是ACOG的官方刊物。通常被称为&ldquo;绿色杂志&rdquo;。 American College of Obstetricians and Gynecologists, copyright=0, guiderPublishedTime=Thu Jan 24 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>2019年1月,美国妇产科医师学会(ACOG)发布了关于胎儿生长受限的实践指南临时更新版本。胎儿生长受限也称宫内生长受限,是妊娠常见并发症多与各种不良围产结局相关。本文主要针对胎儿生长受限的相关术语,病因学,诊断,监测以及分娩的管理提出指导建议。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>胎儿</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=7bbc21c001668856" title="“2018年美国母胎医学会胎儿轻度侧脑室增宽诊断、评估、管理指南”解读" target=_blank>“2018年美国母胎医学会胎儿轻度侧脑室增宽诊断、评估、管理指南”解读</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=72aac1c00165086c" title="2018 SOGC临床实践指南:产前糖皮质激素治疗改善胎儿结局(No.364)" target=_blank>2018 SOGC临床实践指南:产前糖皮质激素治疗改善胎儿结局(No.364)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=27c091c001628a58" title="2018 SOGC临床实践指南:非免疫性胎儿水肿的调查和管理(No.363)" target=_blank>2018 SOGC临床实践指南:非免疫性胎儿水肿的调查和管理(No.363)</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=778591c00153666f" title="妊娠期甲状腺疾病对胎儿及新生儿的影响:解读2017年美国甲状腺学会“妊娠期和产后甲状腺疾病诊治指南" target=_blank>妊娠期甲状腺疾病对胎儿及新生儿的影响:解读2017年美国甲状腺学会“妊娠期和产后甲状腺疾病诊治指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=241a51c001526199" title="非免疫性胎儿水肿临床指南" target=_blank>非免疫性胎儿水肿临床指南</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E8%83%8E%E5%84%BF" target=_blank>有关胎儿更多指南</a></ul>, tagList=[TagDto(tagId=25072, tagName=胎儿生长受限)], categoryList=[CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=其他, guiderLanguage=0, guiderRegion=1, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7455, appHits=398, showAppHits=3, pcHits=5288, showPcHits=2521, likes=109, shares=31, comments=3, approvalStatus=1, publishedTime=Fri Feb 08 22:03:05 CST 2019, publishedTimeString=2019-01-24, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Feb 08 22:03:05 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 16:17:08 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 ACOG实践简报:胎儿生长受限(No.204))])
2019 ACOG实践简报:胎儿生长受限(No.204)
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2097122, encodeId=4c92209e122bf, content=需要哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6788402022, createdName=ms8000000208698829, createdTime=Fri Oct 28 19:46:08 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954460, encodeId=d4e995446014, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:02:11 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897252, encodeId=1e3c89e2522c, content=需要需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49d42576659, createdName=125958ecm25暂无昵称, createdTime=Fri Nov 06 09:10:37 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
    2022-10-28 ms8000000208698829

    需要哦

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2097122, encodeId=4c92209e122bf, content=需要哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6788402022, createdName=ms8000000208698829, createdTime=Fri Oct 28 19:46:08 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954460, encodeId=d4e995446014, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:02:11 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897252, encodeId=1e3c89e2522c, content=需要需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49d42576659, createdName=125958ecm25暂无昵称, createdTime=Fri Nov 06 09:10:37 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
    2021-04-07 湘雅科教

    受益匪浅!好文章。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2097122, encodeId=4c92209e122bf, content=需要哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d6788402022, createdName=ms8000000208698829, createdTime=Fri Oct 28 19:46:08 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954460, encodeId=d4e995446014, content=受益匪浅!好文章。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6c905475903, createdName=湘雅科教, createdTime=Wed Apr 07 13:02:11 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=897252, encodeId=1e3c89e2522c, content=需要需要, beContent=null, objectType=guider, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=49d42576659, createdName=125958ecm25暂无昵称, createdTime=Fri Nov 06 09:10:37 CST 2020, time=2020-11-06, status=1, ipAttribution=)]
    2020-11-06 125958ecm25暂无昵称

    需要需要

    0